Delivery Order SPE2DB24D1021-SPE2DB25FFBEQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,081.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 10, 2025. This firm fixed price delivery order, with an ultimate completion date of September 11, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and serves as...
- The Defense Logistics Agency awarded a delivery order valued at $12,759.36 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,225.77 to supply Mounjaro (tirzepatide) 5 mg/0.5 mL pens, with a completion date of August 4, 2025. This competitively awarded, firm fixed-price contract does not include a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,537.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL unit doses. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,800.96 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 29, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,724.87 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 9, 2025, with completion scheduled for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a pharmaceutical supply delivery under DLA's medical procurement operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $60,990.95 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens (tirzepatide), a diabetes treatment medication. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The $45,378.33 firm fixed-price contract has an ultimate completion date of October 24, 2024. AmerisourceBergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), has an extensive history of federal contract awards with DLA and other agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,090.44 firm fixed-price delivery order is for the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pen with a completion date of May 1, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $4,645.08 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a single delivery order for the diabetes medication to support federal healthcare needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBEQDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,728.97 by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a discrete pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical supply chain regularly utilizes such delivery orders to fulfill critical pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with AmerisourceBergen's extensive portfolio demonstrating its capability to meet diverse federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/26/25 |